| Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls M Maruyama, H Shimada, T Suhara, H Shinotoh, B Ji, J Maeda, ... Neuron 79 (6), 1094-1108, 2013 | 827 | 2013 |
| 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer’s disease MT Fodero-Tavoletti, N Okamura, S Furumoto, RS Mulligan, AR Connor, ... Brain 134 (4), 1089-1100, 2011 | 399 | 2011 |
| 18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease R Harada, N Okamura, S Furumoto, K Furukawa, A Ishiki, N Tomita, ... Journal of Nuclear Medicine 57 (2), 208-214, 2016 | 356 | 2016 |
| Functional anatomy of GO/NO-GO discrimination and response selection—a PET study in man R Kawashima, K Satoh, H Itoh, S Ono, S Furumoto, R Gotoh, M Koyama, ... Brain research 728 (1), 79-89, 1996 | 355 | 1996 |
| Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease N Okamura, S Furumoto, R Harada, T Tago, T Yoshikawa, ... Journal of Nuclear Medicine 54 (8), 1420-1427, 2013 | 334 | 2013 |
| 2-(2-[2-Dimethylaminothiazol-5-yl] ethenyl)-6-(2-[fluoro] ethoxy) benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients Y Kudo, N Okamura, S Furumoto, M Tashiro, K Furukawa, M Maruyama, ... Journal of Nuclear Medicine 48 (4), 553-561, 2007 | 305 | 2007 |
| Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using 18F-THK5105 PET N Okamura, S Furumoto, MT Fodero-Tavoletti, RS Mulligan, R Harada, ... Brain 137 (6), 1762-1771, 2014 | 304 | 2014 |
| Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease N Okamura, T Suemoto, S Furumoto, M Suzuki, H Shimadzu, H Akatsu, ... Journal of Neuroscience 25 (47), 10857-10862, 2005 | 272 | 2005 |
| In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease VL Villemagne, S Furumoto, MT Fodero-Tavoletti, RS Mulligan, J Hodges, ... European journal of nuclear medicine and molecular imaging 41, 816-826, 2014 | 209 | 2014 |
| Tau PET imaging in Alzheimer’s disease N Okamura, R Harada, S Furumoto, H Arai, K Yanai, Y Kudo Current neurology and neuroscience reports 14, 1-7, 2014 | 193 | 2014 |
| Correlations of 18F-THK5351 PET with postmortem burden of tau and astrogliosis in Alzheimer disease R Harada, A Ishiki, H Kai, N Sato, K Furukawa, S Furumoto, T Tago, ... Journal of nuclear medicine 59 (4), 671-674, 2018 | 153 | 2018 |
| Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer’s disease pathology R Harada, N Okamura, S Furumoto, T Tago, M Maruyama, M Higuchi, ... European journal of nuclear medicine and molecular imaging 40, 125-132, 2013 | 142 | 2013 |
| In vivo visualization of α-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission … A Kikuchi, A Takeda, N Okamura, M Tashiro, T Hasegawa, S Furumoto, ... Brain 133 (6), 1772-1778, 2010 | 134 | 2010 |
| [18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease R Harada, N Okamura, S Furumoto, K Furukawa, A Ishiki, N Tomita, ... European journal of nuclear medicine and molecular imaging 42, 1052-1061, 2015 | 131 | 2015 |
| In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET A Kikuchi, N Okamura, T Hasegawa, R Harada, S Watanuki, Y Funaki, ... Neurology 87 (22), 2309-2316, 2016 | 123 | 2016 |
| In vitro characterisation of BF227 binding to α-synuclein/Lewy bodies MT Fodero-Tavoletti, RS Mulligan, N Okamura, S Furumoto, CC Rowe, ... European journal of pharmacology 617 (1-3), 54-58, 2009 | 117 | 2009 |
| [18F] Fluoromethyl triflate, a novel and reactive [18F] fluoromethylating agent: preparation and application to the on-column preparation of [18F] fluorocholine R Iwata, C Pascali, A Bogni, S Furumoto, K Terasaki, K Yanai Applied radiation and isotopes 57 (3), 347-352, 2002 | 117 | 2002 |
| Tumor detection using 18F-labeled matrix metalloproteinase-2 inhibitor S Furumoto, K Takashima, K Kubota, T Ido, R Iwata, H Fukuda Nuclear medicine and biology 30 (2), 119-125, 2003 | 110 | 2003 |
| Tau imaging with [18F]THK‐5351 in progressive supranuclear palsy A Ishiki, R Harada, N Okamura, N Tomita, CC Rowe, VL Villemagne, ... European journal of neurology 24 (1), 130-136, 2017 | 109 | 2017 |
| Characteristics of tau and its ligands in PET imaging R Harada, N Okamura, S Furumoto, T Tago, K Yanai, H Arai, Y Kudo Biomolecules 6 (1), 7, 2016 | 109 | 2016 |
